Cardiovascular imaging is entering a new phase - one where earlier detection, clearer visualization, and more confident decision-making are becoming the standard.

In a recent episode of The Imaging Wire Show, Dr. John Osborne, Chief Medical Officer at Clear Cardio, shares how advances in cardiac CT and AI are transforming the way clinicians detect and manage cardiovascular plaque—with United Imaging's uCT^® ATLAS at the center of that shift.

"My ultimate goal is that we eliminate heart disease, but I will say we are not going to be able to do that without imaging."

Dr. Osborne highlights how modern CT technology now allows clinicians to detect plaque "literally years or even decades before they ever began to have symptoms," enabling a more proactive approach to patient care.

With the uCT^® ATLAS, this level of insight is paired with advanced performance:

• High temporal and spatial resolution for detailed cardiac imaging 
• 16 cm whole-organ coverage supporting fast, efficient acquisition 
• AI-driven capabilities that enhance workflow, image quality, and enable lower dose to patients.

These capabilities are changing how clinicians practice.

"It accomplished what was usually really impossible to do; better quality images, cleaner quality, (and) better signal-to-noise ratio with our images, and at the same time, much lower radiation."

For Dr. Osborne, the impact is clear - cardiac CT has become central to how he evaluates and manages patients, offering a more definitive view of disease than traditional approaches.

Watch the full interview to hear how cardiac CT and AI are advancing plaque detection and redefining cardiovascular care.